Elon Musk, the billionaire founder of Neuralink, announced a significant milestone for the brain-chip startup.
On Sunday, the company successfully implanted its first brain chip in a human patient who is reportedly recovering well.
Musk, sharing the news on social media platform X, highlighted the implant’s promising early results in detecting neuron spikes.
This groundbreaking procedure comes after the U.S. Food and Drug Administration (FDA) permitted Neuralink to begin human trials last year.
Musk revealed in another post on the same platform that the implant, Telepathy, is the first product from Neuralink.
The ongoing PRIME Study by Neuralink, a trial for its wireless brain-computer interface, aims to ensure the safety of the implant and the surgical robot used in the procedure.
The study focuses on the interface’s functionality, designed to help people with quadriplegia control devices using their thoughts.
Recruitment for the study began in September last year, as stated on Neuralink’s website.
However, Neuralink should have provided further details when Reuters reached out.
The company has recently faced scrutiny over its safety protocols.
Earlier this month, Reuters reported that Neuralink was fined for violating U.S. Department of Transportation rules for transporting hazardous materials.
Additionally, last November, four U.S. lawmakers requested an investigation by the U.S. Securities and Exchange Commission into Musk’s statements about the safety of Neuralink’s brain implant, raising concerns of possible securities fraud.
Post's Author
